Free eosinophil granules in urticaria: A correlation with the duration of wheals

American Journal of Dermatopathology

Volumn 18, Issue 1, 1996, Pages 49-57

  Toyoda, Masahiko ^a,b   Maruyama, Tomohiro ^a   Morohashi, Masaaki ^a   Bhawan, Jag ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eosinophil; Free eosinophil granule; Mast cell; Urticaria; Wheal

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MICROSCOPY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; URTICARIA;

ADOLESCENT; ADULT; CYTOPLASMIC GRANULES; EOSINOPHILS; FEMALE; HUMANS; MALE; MAST CELLS; MIDDLE AGED; TIME FACTORS; URTICARIA;

EID: 0029923469     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199602000-00008     Document Type: Article

References (25)

1. Soter NA, Wasserman IS, Austen KF, McFadden ER Jr. Release of mast-cell - mediators and alterations in lung function in patients with cholinergic urticaria. N Engl J Med 1980;302:604-8.
2. Natbony SF, Phillips ME, Elias JM, Godfrey HP, Kaplan AP. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 1983;71:177-83.
3. Schwartz LB. Mast cells and their role in urticaria. J Am Acad Dermatol 1991;25:190-204.
4. Cohen RW, Rosenstreich DL. Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. J Allergy Clin Immunol 1986;77:802-7.
5. Leiferman KM, Haugen HS, Gleich GJ. Evidence for eosinophil degranulation in the late phase of the immediate wheat and flare skin reaction. J Invest Dermatol 1986;86:488.
6. Peters MS, Schroeter AL, Kephart GM, Gleich GJ. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol 1983;81:39-43.
7. Juhlin L. Role of eosinophil granule proteins. In: Burgdorf WHC, Katz SI, eds. Dermatology - progress and perspectives: the proceedings of the 18th World Congress of Dermatology. New York: Parthenon, 1992:736-8.
8. Tsuda S, Miyasato M, Iryo K, Nakama T, Kato K, Sasai Y. Eosinophil phenotypes in bullous pemphigoid. J Dermatol 1992;19:270-9.
9. Tai PC, Spry CJ, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984;309:182-4.
10. Henderson WR, Chi EY. Ultrastructural characterization and morphometric analysis of human eosinophil degranulation. J Cell Sci 1985;73:33-48.
11. Okuda M, Takenaka T, Kawabori S. Ultrastructural study of the specific granule of the human eosinophils. J Submicrosc Cytol 1981;13:465-71.
12. Solley GO, Gleich GJ, Jordan RE, Schroeter AL. The late-phase of the immediate wheal-and-flare reaction: its dependence upon IgE antibodies. J Clin Invest 1976;58:408-20.
13. Stern JB, Sobel HJ, Rotchford JP. Wells' syndrome: is there collagen damage in the flame figures? J Cutan Pathol 1984;11:501-5.
14. O'Donnell MC, Ackerman SJ, Gleich GJ. Activation of basophil and mast cell histamine release by eosinophil major basic protein. J Exp Med 1983;157:1981-91.
15. Henderson WR, Cji Y, Klebanoff SJ. Eosinophil peroxidase-induced mast cell secretion. J Exp Med 1980;152:265-79.
16. Zheutlin LM, Ackerman SJ, Gleich GL. Stimulation of basophil and mast cell histamine release by eosinophil granule derived cationic protein. J Immunol 1984;133:2180-5.
17. Parmley RT, Spicer SS. Altered tissue eosinophils in Hodgkin's disease. Exp Mol Pathol 1975;23:70-82.
18. Dvorak AM. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: cytotoxic potential in Crohn's disease. J Immunol 1980;125:460-2.
19. Dvorak AM, Mihn MC, Dvorak HF. Morphology of delayed-type hypersensitivity reactions in man. 2. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab Invest 1976;34:179-91.
20. Wassom DL, Loegering DA, Solley GO, et al. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest 1981;67:651-61.
21. Stevens RL, Fox CC, Lichtenstein LM, Austen KF. Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Proc Natl Acad Sci USA 1988;85:2284-7.
22. Tharp MD. Role of lymphocytes and histamine releasing factors. In: Burgdorf WHC, Katz SI, eds. Dermatology - progress and perspectives: the proceedings of the 18th World Congress of Dermatology. New York: Parthenon, 1992:728-31.
23. Maruyama T, Toyoda M, Morohashi M, Takaya K. An electron-microscopic study of the mast cell in obstinate cases of atopic dermatitis: morphology of specific granules and cluster formation. In: Ishibashi Y, Nakagawa H, Suzuki H, eds. Electron microscopy in dermatology - basic and clinical research: proceedings of the joint meeting for the Japanese Society for Ultrastructural Cutaneous Biology and the Society for Cutaneous Ultrastructure Research. Nara, Japan: Excerpta Medica, 1994:391-7.
24. Dvorak HF, Mihm MC, Dvorak AM, et al. Morphology of delayed type hypersensitivity reactions in man. 1. Quantitative description of the inflammatory response. Lab Invest 1974;31:111-30.
25. Wasserman SI, Goetzl EJ, Austen KF. Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). J Immunol 1974;112:351-8.